 nc
dupont result came larg in-line compani april pre-
announc underli ep in-line mse ahead
stale consensu ebitda came ahead mse
electron imag transport industri
corpor ahead mse nutrit
bioscienc safeti construct non-cor
mse benefit likewis minor interest tax
much concern debat impact
dupont compani forward look guidanc inform follow
electron imag continu strength semiconductor
volum growth cost take drive leverag compar
mse sale growth ebitda growth nutrit bioscienc
continu strength probiot home person care anim
nutrit biorefineri microbi challeng compar mse
sale growth ebitda growth transport industri volum
significantli impact anticip declin auto build price
mid-singl digit versu nylon headwind lower product volum
pressur margin fix cost headwind idl plant compar mse
sale growth ebitda growth safeti construct
continu strength protect garment water solut shelter
industri market soften manag product across busi ex
garment drive work capit improv pressur margin
compar mse sale growth ebitda growth non-cor
broad base soft end-market contract million gain
associ custom settlement expect compar mse
sale growth ebitda growth
addit step compani take delay certain capit invest
expect reduc capit expenditur million versu prior year
idl product sever manufactur site predominantli product
plant within transport industri segment due current global
automot environ acceler work capit initi across
busi increas anticip benefit increment cost
action previous announc target million save
enter billion revolv credit facil replac
million revolv credit facil set expir june issu
chemic unit state america
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
billion bond offer proce use satisfi debt
matur due novemb facil replac billion
delayed-draw facil announc april
act financi advisor intern flavor fragranc
inc relat definit merger agreement dupont de nemour
inc dupont pursuant combin dupont nutrit
bioscienc busi revers morri trust transact announc
decemb propos transact subject iff sharehold
approv regulatori approv customari close condit report
inform provid herein intend provid vote advic ii
serv endors propos transact iii result
procur withhold revoc proxi action secur
holder agre pay fee financi servic
includ transact fee conting upon consumm
transact pleas refer note end report
corpor
